Apyx Medical (APYX) Reports Q3 Loss, Lags Revenue Estimates
Portfolio Pulse from
Apyx Medical (APYX) reported a Q3 loss of $0.14 per share, slightly better than the Zacks Consensus Estimate of a $0.15 loss, but worse than the $0.13 loss per share from a year ago. The company also lagged in revenue estimates.
November 08, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Apyx Medical reported a Q3 loss of $0.14 per share, slightly better than expected but worse than last year, and missed revenue estimates.
The reported loss per share was slightly better than the consensus estimate, which might have a minor positive impact. However, the fact that the loss was worse than the previous year and that revenue estimates were missed suggests a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100